Navigation Links
New Data Show That Herceptin, Xeloda and Avastin Help Patients With Early and Advanced Breast Cancer Live Longer or Remain Disease Free for Longer
Date:12/10/2008

BASEL, Switzerland, Dec. 10 /PRNewswire/ -- New data being presented at the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) show that Herceptin (trastuzumab), Avastin (bevacizumab) and oral Xeloda (capecitabine) continue to offer new and better treatment options for breast cancer patients allowing women to live longer or remain disease-free for longer if the medicines are given before and after surgery as well as in advanced stages of disease.

    Key data being presented include:

    - Herceptin before surgery: Results from the NOAH (NeOAdjuvant Herceptin)
      phase III study showed that women with locally advanced HER2-positive
      breast cancer who started a combination of Herceptin and standard
      chemotherapy prior to surgery had a significantly greater chance of
      living free of their disease (event-free survival) three years after
      initiation of treatment as compared to women who were receiving pre-
      operative chemotherapy alone.

    - Xeloda in early breast cancer: Early data from an independent study in
      Finland and Sweden indicate that the chemotherapy pill Xeloda, which is
      already proven in advanced breast cancer, may also reduce the
      recurrence of early breast cancer and help women live longer. This is
      one of 20 Xeloda abstracts that have been accepted for presentation
      during SABCS.

    - Avastin in advanced breast cancer: First efficacy results from the
      largest ever safety study of Avastin in a real-life setting, which
      involved more than 2,000 patients with locally recurrent or metastatic
      breast cancer, confirm that Avastin can be used with a broad range of
      chemotherapy treatments giving patients a median of almost 10 months
      without their disease getting worse. The results, which are one of 24
      separate Avastin data presentations during SABCS, confirm that Avastin
      based therapy is essential for improving the li
'/>"/>
SOURCE Roche
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Micromet Demonstrates That the Antibodies in Commercial Products Herceptin, Erbitux, Vectibix and Xolair Can Be Converted Into Highly Potent, T Cell- Engaging BiTE Antibodies
2. Xeloda XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
3. Xeloda(R) XeNA Study Analyses of Xeloda, Docetaxel and Herceptin Combination Therapy for Metastatic Breast Cancer Featured at Major New Breast Cancer Symposium
4. Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting
5. Over 30 New Studies of Oral Xeloda(R) Featured at the 2008 Gastrointestinal Cancers Symposium
6. Novel Xeloda(R) Dosing Schedule May Offer Well-Tolerated Alternative for Treatment of Advanced Breast Cancer
7. Nearly 60 New Studies of Oral Xeloda(R) (capecitabine) Featured at the 44th American Society of Clinical Oncology Annual Meeting
8. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
9. Avastin Achieves Impressive Rate of Curative Surgery in Patients with Advanced Colorectal Cancer
10. New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models
11. Pilot Study Opens the Door for Avastin Use in Curative Setting for Women With Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... 2014  ConvaTec, a privately-held medical products and technologies ... been appointed chief financial officer of the company, effective ... executive vice president and chief financial officer of Elan ... Mr. Clerkin was part of a senior team that ... its sale to Perrigo, a pharmaceutical manufacturer, in December ...
(Date:7/22/2014)... , July 22, 2014  According to the American ... children spend on digital devices. An AOA survey reports ... 10 and 17 estimate they use an electronic device ... separate AOA survey of parents revealed that only 40 ... device for that same amount of time. Eye doctors ...
(Date:7/22/2014)... , July 22, 2014  NeuroSigma, Inc. (NeuroSigma), ... focused on commercialization of its non-invasive Monarch ... and neuropsychiatric disorders, today announced that enrollment has begun ... nerve stimulation (eTNS) as adjunctive therapy for the treatment ... being conducted at the Olive View-UCLA Medical Center in ...
Breaking Medicine Technology:ConvaTec Names Nigel Clerkin Chief Financial Officer 2Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 2Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 3Survey Reveals Parents Drastically Underestimate the Time Kids Spend on Electronic Devices 4Enrollment Commences in NeuroSigma-Sponsored Pediatric Clinical Trial for the Treatment of Lennox-Gastaut Syndrome 2Enrollment Commences in NeuroSigma-Sponsored Pediatric Clinical Trial for the Treatment of Lennox-Gastaut Syndrome 3Enrollment Commences in NeuroSigma-Sponsored Pediatric Clinical Trial for the Treatment of Lennox-Gastaut Syndrome 4Enrollment Commences in NeuroSigma-Sponsored Pediatric Clinical Trial for the Treatment of Lennox-Gastaut Syndrome 5
... Infection Prevention Professionals With Guidelines,and Tools, ... Association for,Professionals in Infection Control and ... new educational initiatives aimed at eliminating,healthcare-associated ... and the three infections that the ...
... Innocoll, Inc., a privately-held,specialty pharmaceutical company, announced ... clinical trials sponsored by its wholly owned ... TOPICAL for the,treatment and prevention of infected ... GENTAMICIN TOPICAL is a biodegradable and fully ...
Cached Medicine Technology:APIC Launches 'Targeting Zero' Initiative to Eradicate C. Difficile and Infections Deemed Preventable By CMS 2APIC Launches 'Targeting Zero' Initiative to Eradicate C. Difficile and Infections Deemed Preventable By CMS 3Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers 2Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers 3Innocoll Announces Dosing of First Patient in US Phase 2 Clinical Trial to Investigate CollaRx(R) GENTAMICIN TOPICAL for the Treatment of Mildly Infected Diabetic Foot Ulcers 4
(Date:7/22/2014)... July 22, 2014 (HealthDay News) -- Genetic fragments of the ... barn where an infected camel was kept, a new study ... to determine if Middle East Respiratory Syndrome (MERS) can be ... air samples over three consecutive days from a camel barn ... of the town of Jeddah, Saudi Arabia. The man later ...
(Date:7/22/2014)... electroconvulsive therapy (ECT) and transcranial magnetic stimulation (TMS), ... Like antidepressant medications, however, they typically have a ... several weeks of regular ECT treatments before a ... an impetus to develop antidepressant treatments that act ... (LFMS) is one such potential new treatment with ...
(Date:7/22/2014)... The “Human Insulin Market by Product ... Modern Human Insulin (Rapid Acting, Long Acting, Premixed)], ... Others) - Forecast to 2019” provides a detailed ... current market trends, and strategies impacting the global ... forecasts of the revenue and share analysis. , ...
(Date:7/22/2014)... Cloud+MD Office 2.0 is a ... medical software and services, designed by experienced healthcare ... “Actionable Information” to help Independent Physician Practices, New ... Services optimize a wide range of business processes ... Noticeable Cost Reductions and Better Patient Care. ...
(Date:7/22/2014)... 2014 For the past nine years, ... been working in tandem to help thousands of cancer ... to care, and help survivors connect to resources dealing ... expanded their partnership to include referrals from PAF to ... the other practical, emotional, and financial issues that accompany ...
Breaking Medicine News(10 mins):Health News:MERS Virus Found in Air in Camel Barn 2Health News:Low strength brain stimulation may be effective for depression 2Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Human Insulin Market Worth $42 Billion by 2019 - New Report by MarketsandMarkets 5Health News:Cloud-MD Software will soon Receive MU2 Certification 2Health News:LIVESTRONG Foundation and Patient Advocate Foundation Expand Partnership to Support the Needs of Cancer Patients and Survivors Nationwide 2Health News:LIVESTRONG Foundation and Patient Advocate Foundation Expand Partnership to Support the Needs of Cancer Patients and Survivors Nationwide 3
... and NEW YORK, Feb. 11 ActivCore ... exclusive distributor of Redcord,products in the United ... with,Wellness in Motion (WIM). ActivCore will ... Training Network that will serve,therapy professionals, chiropractors, ...
... to Make Women,s Concerns Central to National Health ... Stabenow (D-MI), House Democratic Co-Chair of the Congressional ... other Congressional leaders introduced a resolution today that ... will make women,s needs a key part of ...
... announces FDA 510(k) Class,II clearance for the world,s ... respiration rates, bed occupancy and,movement. Under the brand ... device in the US and Canada under an ... 2000 received the sign off from,the FDA,s Division ...
... Demonstrates That Small Gains in Member Retention ... Market research conducted on behalf of ... can significantly improve revenue generation by establishing ... host of economic factors are currently driving ...
... (NYSE: HRC ) invites you to listen ... Investor Relations, Communications and Global Brand,Development, Hill-Rom. He ... in Las Vegas on Tuesday, February 24, 2009, at,9:40 ... invited to listen to the live audio-only webcast via ...
... through Associate Giving CampaignDENVER, Feb. 11 Anthem ... a long history of giving back to the ... 2008, the strong commitment continued through financial support ... Foundation and the generosity of the company,s associates.Anthem,s ...
Cached Medicine News:Health News:ActivCore LLC Announces Strategic Partnership with Wellness in Motion 2Health News:Congressional Leaders, Public Health Experts Announce New Framework to Promote Women's Health 2Health News:Congressional Leaders, Public Health Experts Announce New Framework to Promote Women's Health 3Health News:Sensiotec Announces FDA 510(k) Class II Clearance for the World's First UWB Healthcare Unbound, Wireless, Non-Contact, Vital Signs and Movement Monitor 2Health News:Lowering Health Insurance Member Disenrollment Can Generate up to $100 Million in Incremental Revenue for Health Plans 2Health News:Lowering Health Insurance Member Disenrollment Can Generate up to $100 Million in Incremental Revenue for Health Plans 3Health News:Anthem Blue Cross and Blue Shield in Colorado and its Foundation Commit $1.6 Million in 2008 2Health News:Anthem Blue Cross and Blue Shield in Colorado and its Foundation Commit $1.6 Million in 2008 3Health News:Anthem Blue Cross and Blue Shield in Colorado and its Foundation Commit $1.6 Million in 2008 4
Dnase-free, with an integral filter to protect against carry over and contamination from aerosols...
... TowerPack is an innovative, quick and ... Tips. Use 60% less space on ... plastic. With this amazingly easy-to-use, one-hand ... for the whole range of Diamond ...
300 L, Racked, 96 tips/rack Recommended for 250 and 300 L pipettes. Can also be used with 20, 25, 50, 100 and 200 L pipette...
... to optimize the accuracy and precision of ... is widely recognized by customers throughout the ... over the years and now covers a ... including filter tips, certified pure tips, stepper ...
Medicine Products: